Forward Looking Statements
Certain statements made on this website are forward-looking. Such statements are indicated by words such as "expect," "should," "anticipate" and similar words indicating uncertainty in facts and figures.
Although Synergy believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations reflected in such forward-looking statements will prove to be correct.
As discussed in the Synergy Pharmaceuticals Annual Report on Form 10-K for the year ended December 31, 2008, and other periodic reports, as filed with the Securities and Exchange Commission, actual results could differ materially from those projected in the forward-looking statements as a result of the following factors, among others: uncertainties associated with product development, the risk that products that appeared promising in early clinical trials do not demonstrate efficacy in larger-scale clinical trials, the risk that Synergy will not obtain approval to market its products, the risks associated with dependence upon key personnel and the need for additional financing.
Home >> Legal
January 22, 2010
December 11, 2009
October 8, 2009
Synergy Pharmaceuticals Announces Appointment of Dr. Alan F. Joslyn
October 5, 2009
Synergy Pharmaceuticals to Present at the 17th Annual BioPartnering Europe Conference
July 7, 2009
Synergy Pharmaceuticals Raises $7.09 Million in Common Stock Financing
Synergy Highlights
